Tel:400 179 0116,13012892256,17521589219

Cell, culture reagent, life science research overall service provider!

Current position:Home > Products > Cell Customization > Primary Cells > Human Blood System > pbcd19+/CD5+B-/Human chronic lymphoblastic leukemia pbcd19 + / CD5 + B cells - newly diagnosed / untreated-

Products Resources产品中心

CONTACT US

Current position:Home > Products > Cell Customization > Primary Cells > Human Blood System > pbcd19+/CD5+B-/Human chronic lymphoblastic leukemia pbcd19 + / CD5 + B cells - newly diagnosed / untreated-
  • 人慢性淋巴细胞白血病pbcd19+/CD5+B细胞-新诊断/未治疗

pbcd19+/CD5+B-/Human chronic lymphoblastic leukemia pbcd19 + / CD5 + B cells - newly diagnosed / untreated-

No.:ABC-432

Price: ¥inquiry

specification:
1 vial
amount: - +
  • 人慢性淋巴细胞白血病pbcd19+/CD5+B细胞-新诊断/未治疗
Products Description

Chronic Lymphoid Leukemia-PB-CD19+/CD5+ B cells are isolated from Chronic Lymphoid Leukemia peripheral blood mononuclear cells using a direct immunomagnetic CD19+ MicroBead labeling system. Available in untreated or relapsed/refractory stages. The co-expression of CD5 is typically found on cancerous Chronic Lymphoid LeukemiaCD19+ B cells. Current research is underway to identify the Chronic Lymphoid Leukemia clonal origin of Chronic Lymphoid Leukemia from this cell population. Although these cells appear mature in morphology, they are in developmental arrest. Researchers have shown that only 1% of these cells are in an active cycle. CD19+/CD5+ B cells play an important role in production of IgM autoantibodies.


For research use only

download
Related products
×